Skip to main content
Top
Published in: Malaria Journal 1/2014

Open Access 01-12-2014 | Research

Reduced ADAMTS13 activity is associated with an ADAMTS13 SNP, fever and microparticles in a malaria-like model

Authors: Sirima Kraisin, Attakorn Palasuwan, Supaluk Popruk, Duangdao Nantakomol

Published in: Malaria Journal | Issue 1/2014

Login to get access

Abstract

Background

Severe falciparum malaria (SM) remains a major cause of death in tropical countries. The reduced activity of ADAMTS13, increasing levels of ultra-large von Willebrand factor (ULVWF) in SM patients, are assumed as factors that intensify disease severity. However, the reason why ADAMTS13 activity is reduced in SM remains unclear.

Objectives

To investigate whether rs4962153, febrile temperature, and microparticles, contribute to reduced ADAMTS13 activity.

Methods

Genotypic association of rs4962153 with ADAMTS13 antigen and activity was examined in 362 healthy Thai participants. The collagen binding assay was used to study the effects of febrile temperature and microparticles on ADAMTS13 activity.

Results

ADAMTS13 antigen and activity were decreased in participants with AA genotype, compared to AG and GG (antigen: p-value = 0.014, and < 0.001; activity: p-value = 0.036, and < 0.002, respectively). There was significantly reduced ADAMTS13 antigen in AG compared to GG (p-value = 0.013), but not in ADAMTS13 activity (p-value = 0.082). The number of rs4962153 A alleles correlated with the reduced level of antigen and activity (p-value <0.001 and p-value = 0.001, respectively). MPs showed an inhibitory effect on ADAMTS13 activity (p-value = 0.025). Finally, ADAMTS13 activity was decreased in a temperature and time-dependent manner. The interaction between these two factors was also observed (p-value <0.001).

Conclusions

These findings suggest that the A allele of rs4962153, MPs, and febrile temperature, contribute to reduce ADAMTS13 activity in plasma. These data are useful in malaria or other diseases with reduced ADAMTS13 activity.
Appendix
Available only for authorised users
Literature
1.
go back to reference Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI: The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature. 2005, 434: 214-217. 10.1038/nature03342.PubMedCentralCrossRefPubMed Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI: The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature. 2005, 434: 214-217. 10.1038/nature03342.PubMedCentralCrossRefPubMed
2.
go back to reference de Mast Q, Groot E, Lenting PJ, de Groot PG, McCall M, Sauerwein RW, Fijnheer R, van der Ven A: Thrombocytopenia and release of activated von Willebrand Factor during early Plasmodium falciparum malaria. J Infect Dis. 2007, 196: 622-628. 10.1086/519844.CrossRefPubMed de Mast Q, Groot E, Lenting PJ, de Groot PG, McCall M, Sauerwein RW, Fijnheer R, van der Ven A: Thrombocytopenia and release of activated von Willebrand Factor during early Plasmodium falciparum malaria. J Infect Dis. 2007, 196: 622-628. 10.1086/519844.CrossRefPubMed
3.
go back to reference Hollestelle MJ, Donkor C, Mantey EA, Chakravorty SJ, Craig A, Akoto AO, O’Donnell J, van Mourik JA, Bunn J: von Willebrand factor propeptide in malaria: evidence of acute endothelial cell activation. Br J Haematol. 2006, 133: 562-569. 10.1111/j.1365-2141.2006.06067.x.CrossRefPubMed Hollestelle MJ, Donkor C, Mantey EA, Chakravorty SJ, Craig A, Akoto AO, O’Donnell J, van Mourik JA, Bunn J: von Willebrand factor propeptide in malaria: evidence of acute endothelial cell activation. Br J Haematol. 2006, 133: 562-569. 10.1111/j.1365-2141.2006.06067.x.CrossRefPubMed
4.
go back to reference Larkin D, de Laat B, Jenkins PV, Bunn J, Craig AG, Terraube V, Preston RJ, Donkor C, Grau GE, van Mourik JA, O’Donnell JS: Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition. PLoS Pathog. 2009, 5: e1000349-10.1371/journal.ppat.1000349.PubMedCentralCrossRefPubMed Larkin D, de Laat B, Jenkins PV, Bunn J, Craig AG, Terraube V, Preston RJ, Donkor C, Grau GE, van Mourik JA, O’Donnell JS: Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition. PLoS Pathog. 2009, 5: e1000349-10.1371/journal.ppat.1000349.PubMedCentralCrossRefPubMed
5.
go back to reference Bridges DJ, Bunn J, van Mourik JA, Grau G, Preston RJ, Molyneux M, Combes V, O’Donnell JS, de Laat B, Craig A: Rapid activation of endothelial cells enables Plasmodium falciparum adhesion to platelet-decorated von Willebrand factor strings. Blood. 2010, 115: 1472-1474. 10.1182/blood-2009-07-235150.PubMedCentralCrossRefPubMed Bridges DJ, Bunn J, van Mourik JA, Grau G, Preston RJ, Molyneux M, Combes V, O’Donnell JS, de Laat B, Craig A: Rapid activation of endothelial cells enables Plasmodium falciparum adhesion to platelet-decorated von Willebrand factor strings. Blood. 2010, 115: 1472-1474. 10.1182/blood-2009-07-235150.PubMedCentralCrossRefPubMed
6.
go back to reference Lowenberg EC, Charunwatthana P, Cohen S, van den Born BJ, Meijers JC, Yunus EB, Hassan MU, Hoque G, Maude RJ, Nuchsongsin F, Levi M, Dondorp AM: Severe malaria is associated with a deficiency of von Willebrand factor cleaving protease, ADAMTS13. Thromb Haemost. 2010, 103: 181-187.CrossRefPubMed Lowenberg EC, Charunwatthana P, Cohen S, van den Born BJ, Meijers JC, Yunus EB, Hassan MU, Hoque G, Maude RJ, Nuchsongsin F, Levi M, Dondorp AM: Severe malaria is associated with a deficiency of von Willebrand factor cleaving protease, ADAMTS13. Thromb Haemost. 2010, 103: 181-187.CrossRefPubMed
7.
go back to reference Lotta LA, Garagiola I, Palla R, Cairo A, Peyvandi F: ADAMTS13 mutations and polymorphisms in congenital thrombotic thrombocytopenic purpura. Hum Mutat. 2010, 31: 11-19. 10.1002/humu.21143.CrossRefPubMed Lotta LA, Garagiola I, Palla R, Cairo A, Peyvandi F: ADAMTS13 mutations and polymorphisms in congenital thrombotic thrombocytopenic purpura. Hum Mutat. 2010, 31: 11-19. 10.1002/humu.21143.CrossRefPubMed
8.
go back to reference Kraisin S, Naka I, Patarapotikul J, Nantakomol D, Nuchnoi P, Hananantachai H, Tsuchiya N, Ohashi J: Association of ADAMTS13 polymorphism with cerebral malaria. Malar J. 2011, 10: 366-10.1186/1475-2875-10-366.PubMedCentralCrossRefPubMed Kraisin S, Naka I, Patarapotikul J, Nantakomol D, Nuchnoi P, Hananantachai H, Tsuchiya N, Ohashi J: Association of ADAMTS13 polymorphism with cerebral malaria. Malar J. 2011, 10: 366-10.1186/1475-2875-10-366.PubMedCentralCrossRefPubMed
9.
go back to reference Combes V, Taylor TE, Juhan-Vague I, Mege JL, Mwenechanya J, Tembo M, Grau GE, Molyneux ME: Circulating endothelial microparticles in malawian children with severe falciparum malaria complicated with coma. JAMA. 2004, 291: 2542-2524.PubMed Combes V, Taylor TE, Juhan-Vague I, Mege JL, Mwenechanya J, Tembo M, Grau GE, Molyneux ME: Circulating endothelial microparticles in malawian children with severe falciparum malaria complicated with coma. JAMA. 2004, 291: 2542-2524.PubMed
10.
go back to reference Faille D, El-Assaad F, Alessi MC, Fusai T, Combes V, Grau GE: Platelet-endothelial cell interactions in cerebral malaria: the end of a cordial understanding. Thromb Haemost. 2009, 102: 1093-1102.PubMed Faille D, El-Assaad F, Alessi MC, Fusai T, Combes V, Grau GE: Platelet-endothelial cell interactions in cerebral malaria: the end of a cordial understanding. Thromb Haemost. 2009, 102: 1093-1102.PubMed
11.
go back to reference Nantakomol D, Dondorp AM, Krudsood S, Udomsangpetch R, Pattanapanyasat K, Combes V, Grau GE, White NJ, Viriyavejakul P, Day NP, Chotivanich K: Circulating red cell-derived microparticles in human malaria. J Infect Dis. 2011, 203: 700-706. 10.1093/infdis/jiq104.PubMedCentralCrossRefPubMed Nantakomol D, Dondorp AM, Krudsood S, Udomsangpetch R, Pattanapanyasat K, Combes V, Grau GE, White NJ, Viriyavejakul P, Day NP, Chotivanich K: Circulating red cell-derived microparticles in human malaria. J Infect Dis. 2011, 203: 700-706. 10.1093/infdis/jiq104.PubMedCentralCrossRefPubMed
12.
go back to reference Jy W, Jimenez JJ, Mauro LM, Horstman LL, Cheng P, Ahn ER, Bidot CJ, Ahn YS: Endothelial microparticles induce formation of platelet aggregates via a von Willebrand factor/ristocetin dependent pathway, rendering them resistant to dissociation. J Thromb Haemost. 2005, 3: 1301-1308. 10.1111/j.1538-7836.2005.01384.x.CrossRefPubMed Jy W, Jimenez JJ, Mauro LM, Horstman LL, Cheng P, Ahn ER, Bidot CJ, Ahn YS: Endothelial microparticles induce formation of platelet aggregates via a von Willebrand factor/ristocetin dependent pathway, rendering them resistant to dissociation. J Thromb Haemost. 2005, 3: 1301-1308. 10.1111/j.1538-7836.2005.01384.x.CrossRefPubMed
13.
go back to reference Jimenez JJ, Jy W, Mauro LM, Lens KM, Daghistani N, Dodson HJ, LL H, Ahn Y-S: Activation of endothelial cells (EC) leads to release of inhibitory endothelial microparticles (EMP) and decreased intracellular ADAMTS13 activity. Blood. 2006, 108: 1810- Jimenez JJ, Jy W, Mauro LM, Lens KM, Daghistani N, Dodson HJ, LL H, Ahn Y-S: Activation of endothelial cells (EC) leads to release of inhibitory endothelial microparticles (EMP) and decreased intracellular ADAMTS13 activity. Blood. 2006, 108: 1810-
14.
go back to reference Jy WLA, Bidot L, Bang J, Ahn E, Horstman LL, Jimenez JJ, Bidot CJ: A significant fraction of ADAMTS13 activity is associated with activated platelets and their microparticles (PMP): implication for regulating ADAMTS13 activity. Blood. 2006, 108: 1066- Jy WLA, Bidot L, Bang J, Ahn E, Horstman LL, Jimenez JJ, Bidot CJ: A significant fraction of ADAMTS13 activity is associated with activated platelets and their microparticles (PMP): implication for regulating ADAMTS13 activity. Blood. 2006, 108: 1066-
15.
go back to reference Rock G, Yousef H, Neurath D, Lu M: ADAMTS-13 levels in fresh, stored, and solvent detergent treated plasma. Transfus Apher Sci. 2006, 35: 235-238. 10.1016/j.transci.2006.08.006.CrossRefPubMed Rock G, Yousef H, Neurath D, Lu M: ADAMTS-13 levels in fresh, stored, and solvent detergent treated plasma. Transfus Apher Sci. 2006, 35: 235-238. 10.1016/j.transci.2006.08.006.CrossRefPubMed
16.
go back to reference Gerritsen HE, Robles R, Lammle B, Furlan M: Partial amino acid sequence of purified von Willebrand factor-cleaving protease. Blood. 2001, 98: 1654-1661. 10.1182/blood.V98.6.1654.CrossRefPubMed Gerritsen HE, Robles R, Lammle B, Furlan M: Partial amino acid sequence of purified von Willebrand factor-cleaving protease. Blood. 2001, 98: 1654-1661. 10.1182/blood.V98.6.1654.CrossRefPubMed
17.
go back to reference Gerritsen HE, Turecek PL, Schwarz HP, Lammle B, Furlan M: Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Thromb Haemost. 1999, 82: 1386-1389.PubMed Gerritsen HE, Turecek PL, Schwarz HP, Lammle B, Furlan M: Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Thromb Haemost. 1999, 82: 1386-1389.PubMed
18.
go back to reference Kawasaki A, Kyogoku C, Ohashi J, Miyashita R, Hikami K, Kusaoi M, Tokunaga K, Takasaki Y, Hashimoto H, Behrens TW, Tsuchiya N: Association of IRF5 polymorphisms with systemic lupus erythematosus in a Japanese population: support for a crucial role of intron 1 polymorphisms. Arthritis Rheum. 2008, 58: 826-834. 10.1002/art.23216.CrossRefPubMed Kawasaki A, Kyogoku C, Ohashi J, Miyashita R, Hikami K, Kusaoi M, Tokunaga K, Takasaki Y, Hashimoto H, Behrens TW, Tsuchiya N: Association of IRF5 polymorphisms with systemic lupus erythematosus in a Japanese population: support for a crucial role of intron 1 polymorphisms. Arthritis Rheum. 2008, 58: 826-834. 10.1002/art.23216.CrossRefPubMed
19.
go back to reference Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K: dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001, 29: 308-311. 10.1093/nar/29.1.308.PubMedCentralCrossRefPubMed Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K: dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001, 29: 308-311. 10.1093/nar/29.1.308.PubMedCentralCrossRefPubMed
20.
go back to reference Hanson E, Jood K, Nilsson S, Blomstrand C, Jern C: Association between genetic variation at the ADAMTS13 locus and ischemic stroke. J Thromb Haemost. 2009, 7: 2147-2148. 10.1111/j.1538-7836.2009.03617.x.CrossRefPubMed Hanson E, Jood K, Nilsson S, Blomstrand C, Jern C: Association between genetic variation at the ADAMTS13 locus and ischemic stroke. J Thromb Haemost. 2009, 7: 2147-2148. 10.1111/j.1538-7836.2009.03617.x.CrossRefPubMed
21.
go back to reference Burnier L, Fontana P, Kwak BR, Angelillo-Scherrer A: Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost. 2009, 101: 439-451.PubMed Burnier L, Fontana P, Kwak BR, Angelillo-Scherrer A: Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost. 2009, 101: 439-451.PubMed
22.
go back to reference Faille D, Combes V, Mitchell AJ, Fontaine A, Juhan-Vague I, Alessi MC, Chimini G, Fusai T, Grau GE: Platelet microparticles: a new player in malaria parasite cytoadherence to human brain endothelium. FASEB J. 2009, 23: 3449-3458. 10.1096/fj.09-135822.CrossRefPubMed Faille D, Combes V, Mitchell AJ, Fontaine A, Juhan-Vague I, Alessi MC, Chimini G, Fusai T, Grau GE: Platelet microparticles: a new player in malaria parasite cytoadherence to human brain endothelium. FASEB J. 2009, 23: 3449-3458. 10.1096/fj.09-135822.CrossRefPubMed
23.
go back to reference Furlan M, Robles R, Morselli B, Sandoz P, Lammle B: Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura. Thromb Haemost. 1999, 81: 8-13.PubMed Furlan M, Robles R, Morselli B, Sandoz P, Lammle B: Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura. Thromb Haemost. 1999, 81: 8-13.PubMed
24.
go back to reference Udomsangpetch R, Pipitaporn B, Silamut K, Pinches R, Kyes S, Looareesuwan S, Newbold C, White NJ: Febrile temperatures induce cytoadherence of ring-stage Plasmodium falciparum-infected erythrocytes. Proc Natl Acad Sci U S A. 2002, 99: 11825-11829. 10.1073/pnas.172398999.PubMedCentralCrossRefPubMed Udomsangpetch R, Pipitaporn B, Silamut K, Pinches R, Kyes S, Looareesuwan S, Newbold C, White NJ: Febrile temperatures induce cytoadherence of ring-stage Plasmodium falciparum-infected erythrocytes. Proc Natl Acad Sci U S A. 2002, 99: 11825-11829. 10.1073/pnas.172398999.PubMedCentralCrossRefPubMed
Metadata
Title
Reduced ADAMTS13 activity is associated with an ADAMTS13 SNP, fever and microparticles in a malaria-like model
Authors
Sirima Kraisin
Attakorn Palasuwan
Supaluk Popruk
Duangdao Nantakomol
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2014
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-13-3

Other articles of this Issue 1/2014

Malaria Journal 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine